Search Results

News

Study Finds Increase in Calls to U.S. Poison Control Centers for Natural Psychoactive Substances, Driven by Increase in Marijuana Exposures

A new study conducted by the Center for Injury Research and Policy and the Central Ohio Poison Center at Nationwide Children’s Hospital found there were more than 67,300 calls to U.S. Poison Control Centers regarding exposures to natural psychoactive substances. The study looked at calls from January 2000 through December 2017, which totaled an average of 3,743 exposures each year, or approximately 10 calls every day.

News

While Study Finds Decrease in Eye Exposures Associated with Household Cleaning Products, Experts Still Urge Proper Storage

A new study conducted by the Center for Injury Research and Policy and the Central Ohio Poison Center at Nationwide Children’s Hospital analyzed data regarding eye exposures associated with household cleaning products from 2000 through 2016 and found a decrease in the number of exposures during this period. However, the number of these exposures among young children remains high.

News

Ohio State, Nationwide Children's Hospital First to Offer 'Flash' Proton Therapy

A highly targeted form of proton therapy – known as “FLASH” – will be investigated in clinical trial participants with certain newly diagnosed, recurrent or advanced cancers as part of central Ohio’s first and only proton therapy center, a collaborative effort of The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) and Nationwide Children’s Hospital.

News

First U.S. Trial of DMD Gene Therapy

EMBARGOED FOR RELEASE: 6:00 a.m. Wednesday, March 29, 2006Contacts: Bob Mackle Pam Barber Jade Samulski Director of Public Information Director of Media Relations and Support Services Director of Program Management Muscular Dystrophy Association Columbus Childrens Hospital Asklepios

Article

The Biomedical Interpretation & Training Team

The Biomedical Informatics & Training Team analyzes genomic data from several translational research studies at the Steve and Cindy Rasmussen Institute for Genomic Medicine at Nationwide Children’s Hospital to study the genetic basis of conditions that affect children, particularly rare diseases, epilepsy and pediatric cancers.

Article

TCGA Publications

2016 Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. doi:10.1016/j.cell.2015.12.028 Read the full article 2015 The Molecular Taxonomy of Primary Prostate Cancer. Cell.

Publications

Here are examples of recent publications that arose from collaborative projects between Nephrology and Urology Research Affinity Group (NURAG) investigators: Predicting Outcomes for Children with Congenital Obstructive Uropathy McLeod DJ, Ching CB, Sebastião YV, Greenberg JH, Furth SL,

News

Cure SMA Provides Additional Funding for Promising Spinal Muscular Atrophy Research at Nationwide Childrens Hospital

Cure SMA, the leading organization dedicated to the treatment and cure of spinal muscular atrophy (SMA), recently provided an additional $445,000 grant toward a gene therapy for SMA at Nationwide Children’s Hospital.

News

More than 10,000 Children Involved in School Bus Crashes Annually in Ohio

Each year in the United States, 25.5 million children travel an estimated 4.3 billion miles on school buses. New research findings by investigators in the Center for Injury Research and Policy (CIRP) at Columbus Children’s Hospital emphasize the large number of children involved in school bus